-
1
-
-
0030952289
-
Mechanisms of angiogenesis
-
Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671-674.
-
(1997)
Nature
, vol.386
, pp. 671-674
-
-
Risau, W.1
-
2
-
-
0037699955
-
Angiogenesis in health and disease
-
Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9:653-660.
-
(2003)
Nat Med
, vol.9
, pp. 653-660
-
-
Carmeliet, P.1
-
3
-
-
0036512208
-
New functions for the matrix metalloproteinases in cancer progression
-
Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161-174.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 161-174
-
-
Egeblad, M.1
Werb, Z.2
-
4
-
-
4444304939
-
Regulation of matrix biology by matrix metalloproteinases
-
Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol. 2004;16:558-564.
-
(2004)
Curr Opin Cell Biol
, vol.16
, pp. 558-564
-
-
Mott, J.D.1
Werb, Z.2
-
5
-
-
0037805549
-
Basement membranes: Structure, assembly and role in tumour angiogenesis
-
Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer. 2003;3:422-433.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 422-433
-
-
Kalluri, R.1
-
6
-
-
0030576517
-
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
-
Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-364.
-
(1996)
Cell
, vol.86
, pp. 353-364
-
-
Hanahan, D.1
Folkman, J.2
-
7
-
-
0033944447
-
Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases
-
Yana I, Weiss SJ. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell. 2000;11:2387-2401.
-
(2000)
Mol Biol Cell
, vol.11
, pp. 2387-2401
-
-
Yana, I.1
Weiss, S.J.2
-
8
-
-
0142166332
-
Targeting HIF-1 for cancer therapy
-
Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721-732.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 721-732
-
-
Semenza, G.L.1
-
9
-
-
26444560960
-
Caspases: Pharmacological manipulation of cell death
-
Lavrik IN, Golks A, Krammer PH. Caspases: pharmacological manipulation of cell death. J Clin Invest. 2005;115:2665-2672.
-
(2005)
J Clin Invest
, vol.115
, pp. 2665-2672
-
-
Lavrik, I.N.1
Golks, A.2
Krammer, P.H.3
-
10
-
-
0003931970
-
-
Barrett AJ, Rawlings ND, Woesner JF (eds). Elsevier, Amsterdam
-
Barrett AJ, Rawlings ND, Woesner JF (eds). Handbook of Proteolytic Enzymes (2nd edition), Vol. 1 and 2, Elsevier, Amsterdam, 2004.
-
(2004)
Handbook of Proteolytic Enzymes (2nd Edition)
, vol.1-2
-
-
-
11
-
-
0037693895
-
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry
-
Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92:827-839.
-
(2003)
Circ Res
, vol.92
, pp. 827-839
-
-
Visse, R.1
Nagase, H.2
-
12
-
-
0041737535
-
Molecular mechanisms of glioma invasiveness: The role of proteases
-
Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer. 2003;3:489-501.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 489-501
-
-
Rao, J.S.1
-
13
-
-
20344361933
-
Metalloproteinases and their inhibitors in tumor angiogenesis
-
Handsley MM, Edwards DR. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer. 2005;115:849-860.
-
(2005)
Int J Cancer
, vol.115
, pp. 849-860
-
-
Handsley, M.M.1
Edwards, D.R.2
-
14
-
-
12844286997
-
Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture
-
Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev. 2005;85:1-31.
-
(2005)
Physiol Rev
, vol.85
, pp. 1-31
-
-
Newby, A.C.1
-
15
-
-
0037426578
-
Membrane-type 1 matrix metalloproteinase: A key enzyme for tumor invasion
-
Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett. 2003;194:1-11.
-
(2003)
Cancer Lett
, vol.194
, pp. 1-11
-
-
Seiki, M.1
-
17
-
-
0037155874
-
Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase
-
Deryugina EI, Ratnikov BI, Postnova TI, Rozanov DV, Strongin AY. Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem. 2002;277:9749-9756.
-
(2002)
J Biol Chem
, vol.277
, pp. 9749-9756
-
-
Deryugina, E.I.1
Ratnikov, B.I.2
Postnova, T.I.3
Rozanov, D.V.4
Strongin, A.Y.5
-
18
-
-
0035947675
-
Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion
-
Belkin AM, Akimov SS, Zaritskaya LS, Ratnikov BI, Deryugina EI, Strongin AY. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem. 2001;276:18415-18422.
-
(2001)
J Biol Chem
, vol.276
, pp. 18415-18422
-
-
Belkin, A.M.1
Akimov, S.S.2
Zaritskaya, L.S.3
Ratnikov, B.I.4
Deryugina, E.I.5
Strongin, A.Y.6
-
19
-
-
0035947766
-
Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration
-
Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol. 2001;153:893-904.
-
(2001)
J Cell Biol
, vol.153
, pp. 893-904
-
-
Kajita, M.1
Itoh, Y.2
Chiba, T.3
Mori, H.4
Okada, A.5
Kinoh, H.6
Seiki, M.7
-
20
-
-
15844420283
-
Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
-
Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell. 1996;85:683-693.
-
(1996)
Cell
, vol.85
, pp. 683-693
-
-
Brooks, P.C.1
Stromblad, S.2
Sanders, L.C.3
Von Schalscha, T.L.4
Aimes, R.T.5
Stetler-Stevenson, W.G.6
Quigley, J.P.7
Cheresh, D.A.8
-
21
-
-
0032926177
-
Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion
-
Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 1999;13:35-48.
-
(1999)
Genes Dev
, vol.13
, pp. 35-48
-
-
Yu, Q.1
Stamenkovic, I.2
-
22
-
-
0037224740
-
The ADAMs family of metalloproteases: Multidomain proteins with multiple functions
-
Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 2003;17:7-30.
-
(2003)
Genes Dev
, vol.17
, pp. 7-30
-
-
Seals, D.F.1
Courtneidge, S.A.2
-
24
-
-
0038757017
-
METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity
-
Vazquez F, Hastings G, Ortega MA, Lane TF, Oikemus S, Lombardo M, Iruela-Arispe ML. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem. 1999;274:23349-23357.
-
(1999)
J Biol Chem
, vol.274
, pp. 23349-23357
-
-
Vazquez, F.1
Hastings, G.2
Ortega, M.A.3
Lane, T.F.4
Oikemus, S.5
Lombardo, M.6
Iruela-Arispe, M.L.7
-
26
-
-
0033869721
-
Gene expression profiling in an in vitro model of angiogenesis
-
Kahn J, Mehraban F, Ingle G, Xin X, Bryant JE, Vehar G, Schoenfeld J, Grimaldi CJ, Peale F, Draksharapu A, Lewin DA, Gerritsen ME. Gene expression profiling in an in vitro model of angiogenesis. Am J Pathol. 2000;156:1887-1900.
-
(2000)
Am J Pathol
, vol.156
, pp. 1887-1900
-
-
Kahn, J.1
Mehraban, F.2
Ingle, G.3
Xin, X.4
Bryant, J.E.5
Vehar, G.6
Schoenfeld, J.7
Grimaldi, C.J.8
Peale, F.9
Draksharapu, A.10
Lewin, D.A.11
Gerritsen, M.E.12
-
27
-
-
18244367390
-
The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis
-
Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, Seiki M, Itohara S, Takahashi C, Noda M. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 2001;107:789-800.
-
(2001)
Cell
, vol.107
, pp. 789-800
-
-
Oh, J.1
Takahashi, R.2
Kondo, S.3
Mizoguchi, A.4
Adachi, E.5
Sasahara, R.M.6
Nishimura, S.7
Imamura, Y.8
Kitayama, H.9
Alexander, D.B.10
Ide, C.11
Horan, T.P.12
Arakawa, T.13
Yoshida, H.14
Nishikawa, S.15
Itoh, Y.16
Seiki, M.17
Itohara, S.18
Takahashi, C.19
Noda, M.20
more..
-
28
-
-
0038702657
-
RECK: A novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling
-
Noda M, Oh J, Takahashi R, Kondo S, Kitayama H, Takahashi C. RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastasis Rev. 2003;22:167-175.
-
(2003)
Cancer Metastasis Rev
, vol.22
, pp. 167-175
-
-
Noda, M.1
Oh, J.2
Takahashi, R.3
Kondo, S.4
Kitayama, H.5
Takahashi, C.6
-
29
-
-
0042197340
-
TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism
-
Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, Stetler-Stevenson WG. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 2003;114:171-180.
-
(2003)
Cell
, vol.114
, pp. 171-180
-
-
Seo, D.W.1
Li, H.2
Guedez, L.3
Wingfield, P.T.4
Diaz, T.5
Salloum, R.6
Wei, B.Y.7
Stetler-Stevenson, W.G.8
-
30
-
-
10844219880
-
Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK
-
Oh J, Seo DW, Diaz T, Wei B, Ward Y, Ray JM, Morioka Y, Shi S, Kitayama H, Takahashi C, Noda M, Stetler-Stevenson WG. Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK. Cancer Res. 2004;64:9062-9069.
-
(2004)
Cancer Res
, vol.64
, pp. 9062-9069
-
-
Oh, J.1
Seo, D.W.2
Diaz, T.3
Wei, B.4
Ward, Y.5
Ray, J.M.6
Morioka, Y.7
Shi, S.8
Kitayama, H.9
Takahashi, C.10
Noda, M.11
Stetler-Stevenson, W.G.12
-
31
-
-
1542390484
-
Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: The specificity is in the detail
-
Murphy G, Knauper V, Lee MH, Amour A, Worley JR, Hutton M, Atkinson S, Rapti M, Williamson R. Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. Biochem Soc Symp. 2003;(70):65-80.
-
(2003)
Biochem Soc Symp
, Issue.70
, pp. 65-80
-
-
Murphy, G.1
Knauper, V.2
Lee, M.H.3
Amour, A.4
Worley, J.R.5
Hutton, M.6
Atkinson, S.7
Rapti, M.8
Williamson, R.9
-
32
-
-
0037393850
-
A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): Inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2
-
Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M, Baker A, Anand-Apte B. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med. 2003;9:407-415.
-
(2003)
Nat Med
, vol.9
, pp. 407-415
-
-
Qi, J.H.1
Ebrahem, Q.2
Moore, N.3
Murphy, G.4
Claesson-Welsh, L.5
Bond, M.6
Baker, A.7
Anand-Apte, B.8
-
33
-
-
0035801514
-
Lysosomal cysteine proteases: Facts and opportunities
-
Turk V, Turk B, Turk D. Lysosomal cysteine proteases: facts and opportunities. EMBO J. 2003;20:4629-4633.
-
(2003)
EMBO J
, vol.20
, pp. 4629-4633
-
-
Turk, V.1
Turk, B.2
Turk, D.3
-
34
-
-
0036299011
-
Evolution of placentally expressed cathepsins
-
Sol-Church K, Picerno GN, Stabley DL, Frenck J, Xing S, Bertenshaw GP, Mason RW. Evolution of placentally expressed cathepsins. Biochem Biophys Res Commun. 2002;293:23-29.
-
(2002)
Biochem Biophys Res Commun
, vol.293
, pp. 23-29
-
-
Sol-Church, K.1
Picerno, G.N.2
Stabley, D.L.3
Frenck, J.4
Xing, S.5
Bertenshaw, G.P.6
Mason, R.W.7
-
35
-
-
0036374209
-
Lysosomal cathepsins: Structure, role in antigen processing and presentation, and cancer
-
Turk V, Turk B, Guncar G, Turk D, Kos J. Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv Enzyme Regul. 2002;42:285-303.
-
(2002)
Adv Enzyme Regul
, vol.42
, pp. 285-303
-
-
Turk, V.1
Turk, B.2
Guncar, G.3
Turk, D.4
Kos, J.5
-
36
-
-
21344455498
-
Lysosomal cysteine proteases: Structural features and their role in apoptosis
-
Stoka V, Turk B, Turk V. Lysosomal cysteine proteases: structural features and their role in apoptosis. IUBMB Life. 2005;57:347-353.
-
(2005)
IUBMB Life
, vol.57
, pp. 347-353
-
-
Stoka, V.1
Turk, B.2
Turk, V.3
-
37
-
-
3242812655
-
Cathepsin K is the principal protease in giant cell tumor of bone
-
Lindeman JH, Hanemaaijer R, Mulder A, Dijkstra PD, Szuhai K, Bromme D, Verheijen JH, Hogendoorn PC. Cathepsin K is the principal protease in giant cell tumor of bone. Am J Pathol. 2004;165:593-600.
-
(2004)
Am J Pathol
, vol.165
, pp. 593-600
-
-
Lindeman, J.H.1
Hanemaaijer, R.2
Mulder, A.3
Dijkstra, P.D.4
Szuhai, K.5
Bromme, D.6
Verheijen, J.H.7
Hogendoorn, P.C.8
-
38
-
-
20044373820
-
Cathepsin L is required for endothelial progenitor cell-induced neovascularization
-
Urbich C, Heeschen C, Aicher A, Sasaki K, Bruhl T, Farhadi MR, Vajkoczy P, Hofmann WK, Peters C, Pennacchio LA, Abolmaali ND, Chavakis E, Reinheckel T, Zeiher AM, Dimmeler S. Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat Med. 2005;11:206-213.
-
(2005)
Nat Med
, vol.11
, pp. 206-213
-
-
Urbich, C.1
Heeschen, C.2
Aicher, A.3
Sasaki, K.4
Bruhl, T.5
Farhadi, M.R.6
Vajkoczy, P.7
Hofmann, W.K.8
Peters, C.9
Pennacchio, L.A.10
Abolmaali, N.D.11
Chavakis, E.12
Reinheckel, T.13
Zeiher, A.M.14
Dimmeler, S.15
-
39
-
-
0030788411
-
The urokinase-type plasminogen activator system in cancer metastasis: A review
-
Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer. 1997;72:1-22.
-
(1997)
Int J Cancer
, vol.72
, pp. 1-22
-
-
Andreasen, P.A.1
Kjoller, L.2
Christensen, L.3
Duffy, M.J.4
-
40
-
-
0036906177
-
uPAR: A versatile signalling orchestrator
-
Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol. 2002;3:932-943.
-
(2002)
Nat Rev Mol Cell Biol
, vol.3
, pp. 932-943
-
-
Blasi, F.1
Carmeliet, P.2
-
41
-
-
0035721955
-
Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis
-
Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol. 2001;21:1104-1117.
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.21
, pp. 1104-1117
-
-
Pepper, M.S.1
-
42
-
-
0032826035
-
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
-
Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, Carmeliet P. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med. 1999;5:1135-1142.
-
(1999)
Nat Med
, vol.5
, pp. 1135-1142
-
-
Heymans, S.1
Luttun, A.2
Nuyens, D.3
Theilmeier, G.4
Creemers, E.5
Moons, L.6
Dyspersin, G.D.7
Cleutjens, J.P.8
Shipley, M.9
Angellilo, A.10
Levi, M.11
Nube, O.12
Baker, A.13
Keshet, E.14
Lupu, F.15
Herbert, J.M.16
Smits, J.F.17
Shapiro, S.D.18
Baes, M.19
Borgers, M.20
Collen, D.21
Daemen, M.J.22
Carmeliet, P.23
more..
-
43
-
-
0032531051
-
Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system
-
Carmeliet P, Collen D. Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res. 1998;91:255-285.
-
(1998)
Thromb Res
, vol.91
, pp. 255-285
-
-
Carmeliet, P.1
Collen, D.2
-
44
-
-
2642516344
-
Membrane associated proteases and their inhibitors in tumour angiogenesis
-
Noel A, Maillard C, Rocks N, Jost M, Chabottaux V, Sounni NE, Maquoi E, Cataldo D, Foidart JM. Membrane associated proteases and their inhibitors in tumour angiogenesis. J Clin Pathol. 2004;57:577-584.
-
(2004)
J Clin Pathol
, vol.57
, pp. 577-584
-
-
Noel, A.1
Maillard, C.2
Rocks, N.3
Jost, M.4
Chabottaux, V.5
Sounni, N.E.6
Maquoi, E.7
Cataldo, D.8
Foidart, J.M.9
-
45
-
-
20444421293
-
Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): Cell-surface proteases that activate cell signaling and are potential targets for cancer therapy
-
Kelly T. Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy. Drug Resist Updat. 2005;8:51-58.
-
(2005)
Drug Resist Updat
, vol.8
, pp. 51-58
-
-
Kelly, T.1
-
46
-
-
85047693822
-
Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles
-
Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, Sangkharat A, Ji H, Li L, Michalkiewicz T, Ljubisavljevic M, Johansson H, Grant DS, Zukowska Z. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest. 2003;111:1853-1862.
-
(2003)
J Clin Invest
, vol.111
, pp. 1853-1862
-
-
Lee, E.W.1
Michalkiewicz, M.2
Kitlinska, J.3
Kalezic, I.4
Switalska, H.5
Yoo, P.6
Sangkharat, A.7
Ji, H.8
Li, L.9
Michalkiewicz, T.10
Ljubisavljevic, M.11
Johansson, H.12
Grant, D.S.13
Zukowska, Z.14
-
47
-
-
15944389319
-
Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer
-
Huang Y, Wang S, Kelly T. Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer. Cancer Res. 2004;64:2712-2716.
-
(2004)
Cancer Res
, vol.64
, pp. 2712-2716
-
-
Huang, Y.1
Wang, S.2
Kelly, T.3
-
48
-
-
0031171961
-
Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin
-
Griffith EC, Su Z, Turk BE, Chen S, Chang YH, Wu Z, Biemann K, Liu JO. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem Biol. 1997;4:461-471.
-
(1997)
Chem Biol
, vol.4
, pp. 461-471
-
-
Griffith, E.C.1
Su, Z.2
Turk, B.E.3
Chen, S.4
Chang, Y.H.5
Wu, Z.6
Biemann, K.7
Liu, J.O.8
-
49
-
-
0025204095
-
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
-
Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature. 1990;348:555-557.
-
(1990)
Nature
, vol.348
, pp. 555-557
-
-
Ingber, D.1
Fujita, T.2
Kishimoto, S.3
Sudo, K.4
Kanamaru, T.5
Brem, H.6
Folkman, J.7
-
50
-
-
16644386079
-
Role of aminopeptidase in angiogenesis
-
Sato Y. Role of aminopeptidase in angiogenesis. Biol Pharm Bull. 2004;27:772-776.
-
(2004)
Biol Pharm Bull
, vol.27
, pp. 772-776
-
-
Sato, Y.1
-
51
-
-
0036565887
-
A mouse orthologue of puromycin-insensitive leucyl-specific aminopeptidase is expressed in endothelial cells and plays an important role in angiogenesis
-
Miyashita H, Yamazaki T, Akada T, Niizeki O, Ogawa M, Nishikawa S, Sato Y. A mouse orthologue of puromycin-insensitive leucyl-specific aminopeptidase is expressed in endothelial cells and plays an important role in angiogenesis. Blood. 2002;99:3241-3249.
-
(2002)
Blood
, vol.99
, pp. 3241-3249
-
-
Miyashita, H.1
Yamazaki, T.2
Akada, T.3
Niizeki, O.4
Ogawa, M.5
Nishikawa, S.6
Sato, Y.7
-
52
-
-
0842308319
-
Transmembrane proteases in cell growth and invasion: New contributors to angiogenesis?
-
Bauvois B. Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene. 2004;23:317-329.
-
(2004)
Oncogene
, vol.23
, pp. 317-329
-
-
Bauvois, B.1
-
53
-
-
0033950895
-
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis
-
Pasqualini R, Koivunen E, Kain R, Lahdenranta J, Sakamoto M, Stryhn A, Ashmun RA, Shapiro LH, Arap W, Ruoslahti E. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 2000;60:722-727.
-
(2000)
Cancer Res
, vol.60
, pp. 722-727
-
-
Pasqualini, R.1
Koivunen, E.2
Kain, R.3
Lahdenranta, J.4
Sakamoto, M.5
Stryhn, A.6
Ashmun, R.A.7
Shapiro, L.H.8
Arap, W.9
Ruoslahti, E.10
-
54
-
-
0027195127
-
Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation
-
Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T, Azuma I. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer. 1993;54:137-143.
-
(1993)
Int J Cancer
, vol.54
, pp. 137-143
-
-
Saiki, I.1
Fujii, H.2
Yoneda, J.3
Abe, F.4
Nakajima, M.5
Tsuruo, T.6
Azuma, I.7
-
55
-
-
0036161112
-
Aminopeptidase N is involved in cell motility and angiogenesis: Its clinical significance in human colon cancer
-
Hashida H, Takabayashi A, Kanai M, Adachi M, Kondo K, Kohno N, Yamaoka Y, Miyake M. Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Gastroenterology. 2002;122:376-386.
-
(2002)
Gastroenterology
, vol.122
, pp. 376-386
-
-
Hashida, H.1
Takabayashi, A.2
Kanai, M.3
Adachi, M.4
Kondo, K.5
Kohno, N.6
Yamaoka, Y.7
Miyake, M.8
-
56
-
-
0037372507
-
The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis
-
Bhagwat SV, Petrovic N, Okamoto Y, Shapiro LH. The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis. Blood. 2003;101:1818-1826.
-
(2003)
Blood
, vol.101
, pp. 1818-1826
-
-
Bhagwat, S.V.1
Petrovic, N.2
Okamoto, Y.3
Shapiro, L.H.4
-
57
-
-
0035254206
-
CD13/APN is activated by angiogenic signals and is essential for capillary tube formation
-
Bhagwat SV, Lahdenranta J, Giordano R, Arap W, Pasqualini R, Shapiro LH. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood. 2001;97:652-659.
-
(2001)
Blood
, vol.97
, pp. 652-659
-
-
Bhagwat, S.V.1
Lahdenranta, J.2
Giordano, R.3
Arap, W.4
Pasqualini, R.5
Shapiro, L.H.6
-
58
-
-
0027770021
-
Regulation of matrix metalloproteinases (MMPs) expression in human vein and microvascular endothelial cells. Effects of TNFα, IL-1 and phorbol ester
-
Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJA, van Hinsbergh VWM. Regulation of matrix metalloproteinases (MMPs) expression in human vein and microvascular endothelial cells. Effects of TNFα, IL-1 and phorbol ester. Biochem J. 1993;296:803-809.
-
(1993)
Biochem J
, vol.296
, pp. 803-809
-
-
Hanemaaijer, R.1
Koolwijk, P.2
Le Clercq, L.3
De Vree, W.J.A.4
Van Hinsbergh, V.W.M.5
-
59
-
-
0033597123
-
Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase
-
Rajavashisth TB, Liao JK, Galis ZS, Tripathi S, Laufs U, Tripathi J, Chai NN, Xu XP, Jovinge S, Shah PK, Libby P. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem. 1999;274:11924-11929.
-
(1999)
J Biol Chem
, vol.274
, pp. 11924-11929
-
-
Rajavashisth, T.B.1
Liao, J.K.2
Galis, Z.S.3
Tripathi, S.4
Laufs, U.5
Tripathi, J.6
Chai, N.N.7
Xu, X.P.8
Jovinge, S.9
Shah, P.K.10
Libby, P.11
-
60
-
-
0010712792
-
Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
-
Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell. 1998;92:391-400.
-
(1998)
Cell
, vol.92
, pp. 391-400
-
-
Brooks, P.C.1
Silletti, S.2
Von Schalscha, T.L.3
Friedlander, M.4
Cheresh, D.A.5
-
61
-
-
0032031861
-
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
-
Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 1998;58:1048-1051.
-
(1998)
Cancer Res
, vol.58
, pp. 1048-1051
-
-
Itoh, T.1
Tanioka, M.2
Yoshida, H.3
Yoshioka, T.4
Nishimoto, H.5
Itohara, S.6
-
62
-
-
0000391746
-
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
-
Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2000;2:737-744.
-
(2000)
Nat Cell Biol
, vol.2
, pp. 737-744
-
-
Bergers, G.1
Brekken, R.2
McMahon, G.3
Vu, T.H.4
Itoh, T.5
Tamaki, K.6
Tanzawa, K.7
Thorpe, P.8
Itohara, S.9
Werb, Z.10
Hanahan, D.11
-
63
-
-
2142784516
-
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
-
Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 1999;99:81-92.
-
(1999)
Cell
, vol.99
, pp. 81-92
-
-
Holmbeck, K.1
Bianco, P.2
Caterina, J.3
Yamada, S.4
Kromer, M.5
Kuznetsov, S.A.6
Mankani, M.7
Robey, P.G.8
Poole, A.R.9
Pidoux, I.10
Ward, J.M.11
Birkedal-Hansen, H.12
-
64
-
-
0034635966
-
Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I
-
Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW, Wang J, Cao Y, Tryggvason K. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A. 2000;97:4052-4057.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 4052-4057
-
-
Zhou, Z.1
Apte, S.S.2
Soininen, R.3
Cao, R.4
Baaklini, G.Y.5
Rauser, R.W.6
Wang, J.7
Cao, Y.8
Tryggvason, K.9
-
65
-
-
10744223801
-
Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin
-
Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A, Kalluri R. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell. 2003;3:589-601.
-
(2003)
Cancer Cell
, vol.3
, pp. 589-601
-
-
Hamano, Y.1
Zeisberg, M.2
Sugimoto, H.3
Lively, J.C.4
Maeshima, Y.5
Yang, C.6
Hynes, R.O.7
Werb, Z.8
Sudhakar, A.9
Kalluri, R.10
-
66
-
-
9444274032
-
MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix
-
Chun TH, Sabeh F, Ota I, Murphy H, McDonagh KT, Holmbeck K, Birkedal-Hansen H, Allen ED, Weiss SJ. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol. 2004;167:757-767.
-
(2004)
J Cell Biol
, vol.167
, pp. 757-767
-
-
Chun, T.H.1
Sabeh, F.2
Ota, I.3
Murphy, H.4
McDonagh, K.T.5
Holmbeck, K.6
Birkedal-Hansen, H.7
Allen, E.D.8
Weiss, S.J.9
-
67
-
-
85047691853
-
Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation
-
Balbin M, Fueyo A, Knauper V, Lopez JM, Alvarez J, Sanchez LM, Quesada V, Bordallo J, Murphy G, Lopez-Otin C. Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J Biol Chem. 2001;276:10253-10262.
-
(2001)
J Biol Chem
, vol.276
, pp. 10253-10262
-
-
Balbin, M.1
Fueyo, A.2
Knauper, V.3
Lopez, J.M.4
Alvarez, J.5
Sanchez, L.M.6
Quesada, V.7
Bordallo, J.8
Murphy, G.9
Lopez-Otin, C.10
-
68
-
-
0034927107
-
Plasmin and matrix metalloproteinases in vascular remodeling
-
Lijnen HR. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost. 2001;86:324-333.
-
(2001)
Thromb Haemost
, vol.86
, pp. 324-333
-
-
Lijnen, H.R.1
-
69
-
-
0035060384
-
Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices
-
Davis GE, Pintar Allen KA, Salazar R, Maxwell SA. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J Cell Sci. 2001;114:917-930.
-
(2001)
J. Cell Sci.
, vol.114
, pp. 917-930
-
-
Davis, G.E.1
Pintar Allen, K.A.2
Salazar, R.3
Maxwell, S.A.4
-
70
-
-
0022891340
-
Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
-
Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315:1650-1659.
-
(1986)
N Engl J Med
, vol.315
, pp. 1650-1659
-
-
Dvorak, H.F.1
-
71
-
-
0032582686
-
Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
-
Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell. 1998;95:365-377.
-
(1998)
Cell
, vol.95
, pp. 365-377
-
-
Hiraoka, N.1
Allen, E.2
Apel, I.J.3
Gyetko, M.R.4
Weiss, S.J.5
-
72
-
-
0037017385
-
Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes
-
Hotary KB, Yana I, Sabeh F, et al. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J Exp Med. 2002;195:295-308.
-
(2002)
J Exp Med
, vol.195
, pp. 295-308
-
-
Hotary, K.B.1
Yana, I.2
Sabeh, F.3
-
73
-
-
0029670093
-
Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity
-
Koolwijk P, van Erck MG, de Vree WJ, et al. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol. 1996;132:1177-1188.
-
(1996)
J Cell Biol
, vol.132
, pp. 1177-1188
-
-
Koolwijk, P.1
Van Erck, M.G.2
De Vree, W.J.3
-
74
-
-
0036712828
-
Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs)
-
Lafleur MA, Handsley MM, Knauper V, Murphy G, Edwards DR. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J Cell Sci. 2002;3427-3438.
-
(2002)
J Cell Sci
, pp. 3427-3438
-
-
Lafleur, M.A.1
Handsley, M.M.2
Knauper, V.3
Murphy, G.4
Edwards, D.R.5
-
75
-
-
0037369238
-
Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix
-
Collen A, Hanemaaijer R, Lupu F, Quax PH, van Lent N, Grimbergen J, Peters E, Koolwijk P, van Hinsbergh VW. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Blood. 2003;101:1810-1817.
-
(2003)
Blood
, vol.101
, pp. 1810-1817
-
-
Collen, A.1
Hanemaaijer, R.2
Lupu, F.3
Quax, P.H.4
Van Lent, N.5
Grimbergen, J.6
Peters, E.7
Koolwijk, P.8
Van Hinsbergh, V.W.9
-
76
-
-
8744221615
-
Involvement of membrane-type matrix metalloproteinases in capillary tube formation by human endometrial microvascular endothelial cells. Role of MT3-MMP
-
Plaisier M, Kapiteijn K, Koolwijk P, Fijten C, Hanemaaijer R, Grimbergen JM, Mulder-Stapel A, Quax PHA, Heimerhorst FM, van Hinsbergh VWM. Involvement of membrane-type matrix metalloproteinases in capillary tube formation by human endometrial microvascular endothelial cells. Role of MT3-MMP. J clin Endocrinol Metab. 2004;89:5828-5836.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 5828-5836
-
-
Plaisier, M.1
Kapiteijn, K.2
Koolwijk, P.3
Fijten, C.4
Hanemaaijer, R.5
Grimbergen, J.M.6
Mulder-Stapel, A.7
Quax, P.H.A.8
Heimerhorst, F.M.9
Van Hinsbergh, V.W.M.10
-
77
-
-
27644543354
-
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
-
Abounader R, Laterra J. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro-oncol. 2005;7:436-451.
-
(2005)
Neuro-oncol
, vol.7
, pp. 436-451
-
-
Abounader, R.1
Laterra, J.2
-
78
-
-
0027064888
-
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
-
Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem. 1992;267:26031-26037.
-
(1992)
J Biol Chem
, vol.267
, pp. 26031-26037
-
-
Houck, K.A.1
Leung, D.W.2
Rowland, A.M.3
Winer, J.4
Ferrara, N.5
-
79
-
-
0033490113
-
In vivo angiogenic activity of urokinase: Role of endogenous fibroblast growth factor-2
-
Ribatti D, Leali D, Vacca A, Giuliani R, Gualandris A, Roncali L, Nolli ML, Presta M. In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2. J Cell Sci. 1999;112:4213-4221.
-
(1999)
J Cell Sci
, vol.112
, pp. 4213-4221
-
-
Ribatti, D.1
Leali, D.2
Vacca, A.3
Giuliani, R.4
Gualandris, A.5
Roncali, L.6
Nolli, M.L.7
Presta, M.8
-
80
-
-
0037081306
-
Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis
-
Deryugina EI, Soroceanu L, Strongin AY. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res. 2002;62:580-588.
-
(2002)
Cancer Res
, vol.62
, pp. 580-588
-
-
Deryugina, E.I.1
Soroceanu, L.2
Strongin, A.Y.3
-
81
-
-
18344366604
-
MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression
-
Sounni NE, Devy L, Hajitou A, Frankenne F, Munaut C, Gilles C, Deroanne C, Thompson EW, Foidart JM, Noel A. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J. 2002;16:555-564.
-
(2002)
FASEB J
, vol.16
, pp. 555-564
-
-
Sounni, N.E.1
Devy, L.2
Hajitou, A.3
Frankenne, F.4
Munaut, C.5
Gilles, C.6
Deroanne, C.7
Thompson, E.W.8
Foidart, J.M.9
Noel, A.10
-
82
-
-
11144353715
-
Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases
-
Sounni NE, Roghi C, Chabottaux V, Janssen M, Munaut C, Maquoi E, Galvez BG, Gilles C, Frankenne F, Murphy G, Foidart JM, Noel A. Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases. J Biol Chem. 2004;279:13564-13574.
-
(2004)
J Biol Chem
, vol.279
, pp. 13564-13574
-
-
Sounni, N.E.1
Roghi, C.2
Chabottaux, V.3
Janssen, M.4
Munaut, C.5
Maquoi, E.6
Galvez, B.G.7
Gilles, C.8
Frankenne, F.9
Murphy, G.10
Foidart, J.M.11
Noel, A.12
-
83
-
-
0037183997
-
Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165
-
Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem. 2002;277:36288-36295.
-
(2002)
J Biol Chem
, vol.277
, pp. 36288-36295
-
-
Hashimoto, G.1
Inoki, I.2
Fujii, Y.3
Aoki, T.4
Ikeda, E.5
Okada, Y.6
-
84
-
-
0027380301
-
Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells
-
Yee JA, Yan L, Dominguez JC, Allan EH, Martin TJ. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells. J Cell Physiol. 1993;157:528-534.
-
(1993)
J Cell Physiol
, vol.157
, pp. 528-534
-
-
Yee, J.A.1
Yan, L.2
Dominguez, J.C.3
Allan, E.H.4
Martin, T.J.5
-
85
-
-
0034644472
-
TGFbeta signaling in growth control, cancer, and heritable disorders
-
Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell. 2000;103:295-309.
-
(2000)
Cell
, vol.103
, pp. 295-309
-
-
Massague, J.1
Blain, S.W.2
Lo, R.S.3
-
86
-
-
22344437713
-
Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors
-
Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol. 2005;169:681-691.
-
(2005)
J Cell Biol
, vol.169
, pp. 681-691
-
-
Lee, S.1
Jilani, S.M.2
Nikolova, G.V.3
Carpizo, D.4
Iruela-Arispe, M.L.5
-
87
-
-
1642366238
-
Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity
-
De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R, Zhang HH, Fales H, Tosato G. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood. 2004;103:2452-2459.
-
(2004)
Blood
, vol.103
, pp. 2452-2459
-
-
De La Luz Sierra, M.1
Yang, F.2
Narazaki, M.3
Salvucci, O.4
Davis, D.5
Yarchoan, R.6
Zhang, H.H.7
Fales, H.8
Tosato, G.9
-
88
-
-
20444383082
-
Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation
-
Davis DA, Singer KE, De La Luz Sierra M, Narazaki M, Yang F, Fales HM, Yarchoan R, Tosato G. Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation. Blood. 2005;105:4561-4568.
-
(2005)
Blood
, vol.105
, pp. 4561-4568
-
-
Davis, D.A.1
Singer, K.E.2
De La Luz Sierra, M.3
Narazaki, M.4
Yang, F.5
Fales, H.M.6
Yarchoan, R.7
Tosato, G.8
-
89
-
-
0035941359
-
Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1
-
McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I, Overall CM. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem. 2001;276:43503-43508.
-
(2001)
J Biol Chem
, vol.276
, pp. 43503-43508
-
-
McQuibban, G.A.1
Butler, G.S.2
Gong, J.H.3
Bendall, L.4
Power, C.5
Clark-Lewis, I.6
Overall, C.M.7
-
90
-
-
0036133646
-
Tumor necrosis factor-alpha converting enzyme
-
Black RA. Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol. 2002;34:1-5.
-
(2002)
Int J Biochem Cell Biol
, vol.34
, pp. 1-5
-
-
Black, R.A.1
-
91
-
-
0036796421
-
The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts
-
Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W, Umans L, Lubke T, Lena Illert A, von Figura K, Saftig P. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet. 2002;11:2615-2624.
-
(2002)
Hum Mol Genet
, vol.11
, pp. 2615-2624
-
-
Hartmann, D.1
De Strooper, B.2
Serneels, L.3
Craessaerts, K.4
Herreman, A.5
Annaert, W.6
Umans, L.7
Lubke, T.8
Lena Illert, A.9
Von Figura, K.10
Saftig, P.11
-
92
-
-
1542344524
-
Notch function in the vasculature: Insights from zebrafish, mouse and man
-
Shawber CJ, Kitajewski J. Notch function in the vasculature: insights from zebrafish, mouse and man. Bioessays. 2004;26:225-234.
-
(2004)
Bioessays
, vol.26
, pp. 225-234
-
-
Shawber, C.J.1
Kitajewski, J.2
-
93
-
-
22244460522
-
Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling
-
Zeng Q, Li S, Chepeha DB, Giordano TJ, Li J, Zhang H, Polverini PJ, Nor J, Kitajewski J, Wang CY. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell. 2005;8:13-23.
-
(2005)
Cancer Cell
, vol.8
, pp. 13-23
-
-
Zeng, Q.1
Li, S.2
Chepeha, D.B.3
Giordano, T.J.4
Li, J.5
Zhang, H.6
Polverini, P.J.7
Nor, J.8
Kitajewski, J.9
Wang, C.Y.10
-
94
-
-
0034714357
-
Regulated cleavage of a contact-mediated axon repellent
-
Hattori M, Osterfield M, Flanagan JG. Regulated cleavage of a contact-mediated axon repellent. Science. 2000;289:1360-1305.
-
(2000)
Science
, vol.289
, pp. 1360-1305
-
-
Hattori, M.1
Osterfield, M.2
Flanagan, J.G.3
-
95
-
-
26844448800
-
Adam Meets Eph: An ADAM Substrate Recognition Module Acts as a Molecular Switch for Ephrin Cleavage in trans
-
Janes PW, Saha N, Barton WA, Kolev MV, Wimmer-Kleikamp SH, Nievergall E, Blobel CP, Himanen JP, Lackmann M, Nikolov DB. Adam Meets Eph: An ADAM Substrate Recognition Module Acts as a Molecular Switch for Ephrin Cleavage In trans. Cell. 2005;123:291-304.
-
(2005)
Cell
, vol.123
, pp. 291-304
-
-
Janes, P.W.1
Saha, N.2
Barton, W.A.3
Kolev, M.V.4
Wimmer-Kleikamp, S.H.5
Nievergall, E.6
Blobel, C.P.7
Himanen, J.P.8
Lackmann, M.9
Nikolov, D.B.10
-
96
-
-
18644379904
-
Soluble Eph a receptors inhibit tumor angiogenesis and progression in vivo
-
Brantley DM, Cheng N, Thompson EJ, Lin Q, Brekken RA, Thorpe PE, Muraoka RS, Cerretti DP, Pozzi A, Jackson D, Lin C, Chen J. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene. 2002;21:7011-7026.
-
(2002)
Oncogene
, vol.21
, pp. 7011-7026
-
-
Brantley, D.M.1
Cheng, N.2
Thompson, E.J.3
Lin, Q.4
Brekken, R.A.5
Thorpe, P.E.6
Muraoka, R.S.7
Cerretti, D.P.8
Pozzi, A.9
Jackson, D.10
Lin, C.11
Chen, J.12
-
97
-
-
0032572596
-
Neuropeptide Y: A novel angiogenic factor from the sympathetic nerves and endothelium
-
Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E, Grant DS. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res. 1998;83:187-195.
-
(1998)
Circ Res
, vol.83
, pp. 187-195
-
-
Zukowska-Grojec, Z.1
Karwatowska-Prokopczuk, E.2
Rose, W.3
Rone, J.4
Movafagh, S.5
Ji, H.6
Yeh, Y.7
Chen, W.T.8
Kleinman, H.K.9
Grouzmann, E.10
Grant, D.S.11
-
98
-
-
0031902286
-
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
-
Bajou K, Noel A, Gerard RD, et al. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med. 1998;4:923-928.
-
(1998)
Nat Med
, vol.4
, pp. 923-928
-
-
Bajou, K.1
Noel, A.2
Gerard, R.D.3
-
99
-
-
0035911151
-
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies
-
Bajou K, Masson V, Gerard RD, et al. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol. 2001;152:777-784.
-
(2001)
J Cell Biol
, vol.152
, pp. 777-784
-
-
Bajou, K.1
Masson, V.2
Gerard, R.D.3
-
101
-
-
0034667385
-
Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1
-
Gutierrez LS, Schulman A, Brito-Robinson T, et al. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Cancer Res. 2000;60:5839-5847.
-
(2000)
Cancer Res
, vol.60
, pp. 5839-5847
-
-
Gutierrez, L.S.1
Schulman, A.2
Brito-Robinson, T.3
-
102
-
-
0034923326
-
Protease crosstalk with integrins: The urokinase receptor paradigm
-
Chapman HA, Wei Y. Protease crosstalk with integrins: the urokinase receptor paradigm. Thromb Haemost. 2001;86:124-129.
-
(2001)
Thromb Haemost
, vol.86
, pp. 124-129
-
-
Chapman, H.A.1
Wei, Y.2
-
103
-
-
0038215389
-
Pericellular cathepsin B and malignant progression
-
Roshy S, Sloane BF, Moin K. Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev. 2003;22:271-286.
-
(2003)
Cancer Metastasis Rev
, vol.22
, pp. 271-286
-
-
Roshy, S.1
Sloane, B.F.2
Moin, K.3
-
104
-
-
0010469194
-
Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells
-
Quigley JP, Gold LI, Schwimmer R, Sullivan LM. Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells. Proc Natl Acad Sci U S A. 1987;84:2776-2780.
-
(1987)
Proc Natl Acad Sci U S A
, vol.84
, pp. 2776-2780
-
-
Quigley, J.P.1
Gold, L.I.2
Schwimmer, R.3
Sullivan, L.M.4
-
105
-
-
0033017205
-
Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices
-
Kroon ME, Koolwijk P, van Goor H, Weidle U, Collen A, van der Pluijm G, van Hinsbergh VWM. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices. Am J Pathol,. 1999;154:1731-1742.
-
(1999)
Am J Pathol
, vol.154
, pp. 1731-1742
-
-
Kroon, M.E.1
Koolwijk, P.2
Van Goor, H.3
Weidle, U.4
Collen, A.5
Van Der Pluijm, G.6
Van Hinsbergh, V.W.M.7
-
106
-
-
0025336879
-
The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes
-
Estreicher A, Muhlhauser J, Carpentier JL, Orci L, Vassalli JD. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol. 1990;111:783-792.
-
(1990)
J Cell Biol
, vol.111
, pp. 783-792
-
-
Estreicher, A.1
Muhlhauser, J.2
Carpentier, J.L.3
Orci, L.4
Vassalli, J.D.5
-
107
-
-
0027183188
-
Upregulation of urokinase receptor expression on migrating endothelial cells
-
Pepper MS, Sappino AP, Stocklin R, Montesano R, Orci L, Vassalli JD. Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol. 1993;122:673-684.
-
(1993)
J Cell Biol
, vol.122
, pp. 673-684
-
-
Pepper, M.S.1
Sappino, A.P.2
Stocklin, R.3
Montesano, R.4
Orci, L.5
Vassalli, J.D.6
-
108
-
-
21644432642
-
Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: Generation of a new integrin inhibitor
-
Degryse B, Resnati M, Czekay RP, Loskutoff DJ, Blasi F. Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor. J Biol Chem. 2005;280:24792-24803.
-
(2005)
J Biol Chem
, vol.280
, pp. 24792-24803
-
-
Degryse, B.1
Resnati, M.2
Czekay, R.P.3
Loskutoff, D.J.4
Blasi, F.5
-
109
-
-
0043032575
-
Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling
-
Tarui T, Andronicos N, Czekay RP, Mazar AP, Bdeir K, Parry GC, Kuo A, Loskutoff DJ, Cines DB, Takada Y. Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling. J Biol Chem. 2003;278:29863-29872.
-
(2003)
J Biol Chem
, vol.278
, pp. 29863-29872
-
-
Tarui, T.1
Andronicos, N.2
Czekay, R.P.3
Mazar, A.P.4
Bdeir, K.5
Parry, G.C.6
Kuo, A.7
Loskutoff, D.J.8
Cines, D.B.9
Takada, Y.10
-
110
-
-
13444274458
-
Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding
-
Wei Y, Czekay RP, Robillard L, Kugler MC, Zhang F, Kim KK, Xiong JP, Humphries MJ, Chapman HA. Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding. J Cell Biol. 2005;168:501-511.
-
(2005)
J Cell Biol
, vol.168
, pp. 501-511
-
-
Wei, Y.1
Czekay, R.P.2
Robillard, L.3
Kugler, M.C.4
Zhang, F.5
Kim, K.K.6
Xiong, J.P.7
Humphries, M.J.8
Chapman, H.A.9
-
111
-
-
0033045293
-
Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells
-
Dumler I, Kopmann A, Weis A, Mayboroda OA, Wagner K, Gulba DC, Haller H. Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells. Arterioscler Thromb Vasc Biol. 1999;19:290-297.
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 290-297
-
-
Dumler, I.1
Kopmann, A.2
Weis, A.3
Mayboroda, O.A.4
Wagner, K.5
Gulba, D.C.6
Haller, H.7
-
112
-
-
2142755773
-
The role of plasminogen in angiogenesis in vivo
-
Oh CW, Hoover-Plow J, Plow EF. The role of plasminogen in angiogenesis in vivo. J Thromb Haemost. 2003;1:1683-1687.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 1683-1687
-
-
Oh, C.W.1
Hoover-Plow, J.2
Plow, E.F.3
-
113
-
-
3343006397
-
The role of the fibrinolytic system in corneal angiogenesis
-
Vogten JM, Reijerkerk A, Meijers JC, Voest EE, Borel Rinkes IH, Gebbink MF. The role of the fibrinolytic system in corneal angiogenesis. Angiogenesis. 2003;6:311-316.
-
(2003)
Angiogenesis
, vol.6
, pp. 311-316
-
-
Vogten, J.M.1
Reijerkerk, A.2
Meijers, J.C.3
Voest, E.E.4
Borel Rinkes, I.H.5
Gebbink, M.F.6
-
114
-
-
0035793037
-
Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo
-
Silletti S, Kessler T, Goldberg J, Boger DL, Cheresh DA. Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc Natl Acad Sci U S A. 2001;98:119-124.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 119-124
-
-
Silletti, S.1
Kessler, T.2
Goldberg, J.3
Boger, D.L.4
Cheresh, D.A.5
-
115
-
-
0037064589
-
ECM regulates MT1-MMP localization with beta1 or alphavbeta3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells
-
Galvez BG, Matias-Roman S, Yanez-Mo M, Sanchez-Madrid F, Arroyo AG. ECM regulates MT1-MMP localization with beta1 or alphavbeta3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. J Cell Biol. 2002;159:509-521.
-
(2002)
J Cell Biol
, vol.159
, pp. 509-521
-
-
Galvez, B.G.1
Matias-Roman, S.2
Yanez-Mo, M.3
Sanchez-Madrid, F.4
Arroyo, A.G.5
-
116
-
-
0036683241
-
CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain
-
Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I, Seiki M. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J. 2002;21:3949-3959.
-
(2002)
EMBO J
, vol.21
, pp. 3949-3959
-
-
Mori, H.1
Tomari, T.2
Koshikawa, N.3
Kajita, M.4
Itoh, Y.5
Sato, H.6
Tojo, H.7
Yana, I.8
Seiki, M.9
-
117
-
-
0029949785
-
CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix
-
Henke CA, Roongta U, Mickelson DJ, Knutson JR, McCarthy JB. CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix. J Clin Invest. 1996;97:2541-2552.
-
(1996)
J Clin Invest
, vol.97
, pp. 2541-2552
-
-
Henke, C.A.1
Roongta, U.2
Mickelson, D.J.3
Knutson, J.R.4
McCarthy, J.B.5
-
118
-
-
0035955469
-
Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP)
-
Gingras D, Bousquet-Gagnon N, Langlois S, Lachambre MP, Annabi B, Beliveau R. Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett. 2001;507:231-236.
-
(2001)
FEBS Lett
, vol.507
, pp. 231-236
-
-
Gingras, D.1
Bousquet-Gagnon, N.2
Langlois, S.3
Lachambre, M.P.4
Annabi, B.5
Beliveau, R.6
-
119
-
-
0037063349
-
The cytoplasmic tail peptide sequence of membrane type-1 matrix metalloproteinase (MT1-MMP) directly binds to gC1qR, a compartment-specific chaperone-like regulatory protein
-
Rozanov DV, Ghebrehiwet B, Ratnikov B, Monosov EZ, Deryugina EI, Strongin AY. The cytoplasmic tail peptide sequence of membrane type-1 matrix metalloproteinase (MT1-MMP) directly binds to gC1qR, a compartment-specific chaperone-like regulatory protein. FEBS Lett. 2002;527:51-57.
-
(2002)
FEBS Lett
, vol.527
, pp. 51-57
-
-
Rozanov, D.V.1
Ghebrehiwet, B.2
Ratnikov, B.3
Monosov, E.Z.4
Deryugina, E.I.5
Strongin, A.Y.6
-
120
-
-
1842581954
-
Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein-1 is a new member of the Cupin superfamily. A possible multifunctional protein acting as an invasion suppressor down-regulated in tumors
-
Uekita T, Gotoh I, Kinoshita T, Itoh Y, Sato H, Shiomi T, Okada Y, Seiki M. Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein-1 is a new member of the Cupin superfamily. A possible multifunctional protein acting as an invasion suppressor down-regulated in tumors. J Biol Chem. 2004;279:12734-12743.
-
(2004)
J Biol Chem
, vol.279
, pp. 12734-12743
-
-
Uekita, T.1
Gotoh, I.2
Kinoshita, T.3
Itoh, Y.4
Sato, H.5
Shiomi, T.6
Okada, Y.7
Seiki, M.8
-
121
-
-
0142103466
-
Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration
-
Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, Furukawa M, Sato H. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem. 2003;278:40764-40770.
-
(2003)
J Biol Chem
, vol.278
, pp. 40764-40770
-
-
Endo, K.1
Takino, T.2
Miyamori, H.3
Kinsen, H.4
Yoshizaki, T.5
Furukawa, M.6
Sato, H.7
-
122
-
-
0142011033
-
Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface
-
Remacle A, Murphy G, Roghi C. Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface. J Cell Sci. 2003;116:3905-3916.
-
(2003)
J Cell Sci
, vol.116
, pp. 3905-3916
-
-
Remacle, A.1
Murphy, G.2
Roghi, C.3
-
123
-
-
0742323005
-
Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells
-
Galvez BG, Matias-Roman S, Yanez-Mo M, Vicente-Manzanares M, Sanchez-Madrid F, Arroyo AG. Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol Biol Cell. 2004;15:678-687.
-
(2004)
Mol Biol Cell
, vol.15
, pp. 678-687
-
-
Galvez, B.G.1
Matias-Roman, S.2
Yanez-Mo, M.3
Vicente-Manzanares, M.4
Sanchez-Madrid, F.5
Arroyo, A.G.6
-
124
-
-
0035945354
-
Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity
-
Uekita T, Itoh Y, Yana I, Ohno H, Seiki M. Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol. 2001;155:1345-1356.
-
(2001)
J Cell Biol
, vol.155
, pp. 1345-1356
-
-
Uekita, T.1
Itoh, Y.2
Yana, I.3
Ohno, H.4
Seiki, M.5
-
125
-
-
3042784666
-
Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor
-
Prager GW, Breuss JM, Steurer S, Olcaydu D, Mihaly J, Brunner PM, Stockinger H, Binder BR. Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor. Circ Res. 2004;94:1562-1570.
-
(2004)
Circ Res
, vol.94
, pp. 1562-1570
-
-
Prager, G.W.1
Breuss, J.M.2
Steurer, S.3
Olcaydu, D.4
Mihaly, J.5
Brunner, P.M.6
Stockinger, H.7
Binder, B.R.8
-
126
-
-
0026734254
-
Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B
-
Kobayashi H, Ohi H, Sugimura M, Shinohara H, Fujii T, Terao T. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res. 1992;52:3610-3614.
-
(1992)
Cancer Res
, vol.52
, pp. 3610-3614
-
-
Kobayashi, H.1
Ohi, H.2
Sugimura, M.3
Shinohara, H.4
Fujii, T.5
Terao, T.6
-
127
-
-
3042551389
-
Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas
-
Gondi CS, Lakka SS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Tung CH, Weissleder R, Rao JS. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Cancer Res. 2004;64:4069-4077.
-
(2004)
Cancer Res
, vol.64
, pp. 4069-4077
-
-
Gondi, C.S.1
Lakka, S.S.2
Yanamandra, N.3
Olivero, W.C.4
Dinh, D.H.5
Gujrati, M.6
Tung, C.H.7
Weissleder, R.8
Rao, J.S.9
-
128
-
-
2942718949
-
Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis
-
Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Rao JS. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene. 2004;23:4681-4689.
-
(2004)
Oncogene
, vol.23
, pp. 4681-4689
-
-
Lakka, S.S.1
Gondi, C.S.2
Yanamandra, N.3
Olivero, W.C.4
Dinh, D.H.5
Gujrati, M.6
Rao, J.S.7
-
129
-
-
0032782127
-
Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases
-
Kostoulas G, Lang A, Nagase H, Baici A. Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases. FEBS Lett. 1999;455:286-290.
-
(1999)
FEBS Lett
, vol.455
, pp. 286-290
-
-
Kostoulas, G.1
Lang, A.2
Nagase, H.3
Baici, A.4
-
130
-
-
0037020835
-
Invariant chain controls the activity of extracellular cathepsin L.
-
Fiebiger E, Maehr R, Villadangos J, Weber E, Erickson A, Bikoff E, Ploegh HL, Lennon-Dumenil AM. Invariant chain controls the activity of extracellular cathepsin L. J Exp Med. 2002;196:1263-1269.
-
(2002)
J Exp Med
, vol.196
, pp. 1263-1269
-
-
Fiebiger, E.1
Maehr, R.2
Villadangos, J.3
Weber, E.4
Erickson, A.5
Bikoff, E.6
Ploegh, H.L.7
Lennon-Dumenil, A.M.8
-
131
-
-
0028909688
-
Immunohistochemical localization of cathepsin B in neoplastic human prostate
-
Sinha AA, Wilson MJ, Gleason DF, Reddy PK, Sameni M, Sloane BF. Immunohistochemical localization of cathepsin B in neoplastic human prostate. Prostate. 1995;26:171-178.
-
(1995)
Prostate
, vol.26
, pp. 171-178
-
-
Sinha, A.A.1
Wilson, M.J.2
Gleason, D.F.3
Reddy, P.K.4
Sameni, M.5
Sloane, B.F.6
-
132
-
-
0029097797
-
Immunolocalization of cathepsin B in human glioma: Implications for tumor invasion and angiogenesis
-
Mikkelsen T, Yan PS, Ho KL, Sameni M, Sloane BF, Rosenblum ML. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. J Neurosurg. 1995;83:285-290.
-
(1995)
J Neurosurg
, vol.83
, pp. 285-290
-
-
Mikkelsen, T.1
Yan, P.S.2
Ho, K.L.3
Sameni, M.4
Sloane, B.F.5
Rosenblum, M.L.6
-
133
-
-
2342603891
-
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis
-
Joyce JA, Barach A, Chehade K, Meyer-Morse N, Giraudo E, Tsai FY, Greenbaum DC, Hager JH, Bogyo M, Hanahan D. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell. 2004;5:443-453.
-
(2004)
Cancer Cell
, vol.5
, pp. 443-453
-
-
Joyce, J.A.1
Barach, A.2
Chehade, K.3
Meyer-Morse, N.4
Giraudo, E.5
Tsai, F.Y.6
Greenbaum, D.C.7
Hager, J.H.8
Bogyo, M.9
Hanahan, D.10
-
134
-
-
0037459360
-
Deficiency of the cysteine protease cathepsin S impairs microvessel growth
-
Shi GP, Sukhova GK, Kuzuya M, Ye Q, Du J, Zhang Y, Pan JH, Lu ML, Cheng XW, Iguchi A, Perrey S, Lee AM, Chapman HA, Libby P. Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ Res. 2003;92:493-500.
-
(2003)
Circ Res
, vol.92
, pp. 493-500
-
-
Shi, G.P.1
Sukhova, G.K.2
Kuzuya, M.3
Ye, Q.4
Du, J.5
Zhang, Y.6
Pan, J.H.7
Lu, M.L.8
Cheng, X.W.9
Iguchi, A.10
Perrey, S.11
Lee, A.M.12
Chapman, H.A.13
Libby, P.14
-
135
-
-
0030639289
-
Role of the macrophage in angiogenesis-dependent diseases
-
Polverini PJ. Role of the macrophage in angiogenesis-dependent diseases. EXS. 1997;79:11-28.
-
(1997)
EXS
, vol.79
, pp. 11-28
-
-
Polverini, P.J.1
-
136
-
-
4143052506
-
Endothelial progenitor cells: Characterization and role in vascular biology
-
Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004;95:343-353.
-
(2004)
Circ Res
, vol.95
, pp. 343-353
-
-
Urbich, C.1
Dimmeler, S.2
-
137
-
-
18544367029
-
Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium
-
Matias-Roman S, Galvez BG, Genis L, Yanez-Mo M, de la Rosa G, Sanchez-Mateos P, Sanchez-Madrid F, Arroyo AG. Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium. Blood. 2005;105:3956-3964.
-
(2005)
Blood
, vol.105
, pp. 3956-3964
-
-
Matias-Roman, S.1
Galvez, B.G.2
Genis, L.3
Yanez-Mo, M.4
De La Rosa, G.5
Sanchez-Mateos, P.6
Sanchez-Madrid, F.7
Arroyo, A.G.8
-
138
-
-
0038376000
-
Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration
-
Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702-712.
-
(2003)
Nat Med
, vol.9
, pp. 702-712
-
-
Rafii, S.1
Lyden, D.2
-
139
-
-
0037434561
-
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
-
Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593-600.
-
(2003)
N Engl J Med
, vol.348
, pp. 593-600
-
-
Hill, J.M.1
Zalos, G.2
Halcox, J.P.3
Schenke, W.H.4
Waclawiw, M.A.5
Quyyumi, A.A.6
Finkel, T.7
-
140
-
-
24344442873
-
Circulating endothelial progenitor cells and cardiovascular outcomes
-
Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999-1007.
-
(2005)
N Engl J Med
, vol.353
, pp. 999-1007
-
-
Werner, N.1
Kosiol, S.2
Schiegl, T.3
Ahlers, P.4
Walenta, K.5
Link, A.6
Bohm, M.7
Nickenig, G.8
-
141
-
-
23944518957
-
Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells
-
Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood. 2005;106:1525-1531.
-
(2005)
Blood
, vol.106
, pp. 1525-1531
-
-
Ingram, D.A.1
Caplice, N.M.2
Yoder, M.C.3
-
142
-
-
18444389451
-
Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand
-
Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109:625-637.
-
(2002)
Cell
, vol.109
, pp. 625-637
-
-
Heissig, B.1
Hattori, K.2
Dias, S.3
Friedrich, M.4
Ferris, B.5
Hackett, N.R.6
Crystal, R.G.7
Besmer, P.8
Lyden, D.9
Moore, M.A.10
Werb, Z.11
Rafii, S.12
-
143
-
-
17144430502
-
The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent
-
Jodele S, Chantrain CF, Blavier L, Lutzko C, Crooks GM, Shimada H, Coussens LM, Declerck YA. The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res. 2005;65:3200-3208.
-
(2005)
Cancer Res
, vol.65
, pp. 3200-3208
-
-
Jodele, S.1
Chantrain, C.F.2
Blavier, L.3
Lutzko, C.4
Crooks, G.M.5
Shimada, H.6
Coussens, L.M.7
Declerck, Y.A.8
-
144
-
-
25144474110
-
Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization
-
Heissig B, Rafii S, Akiyama H, Ohki Y, Sato Y, Rafael T, Zhu Z, Hicklin DJ, Okumura K, Ogawa H, Werb Z, Hattori K. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J Exp Med. 2005;202:739-750.
-
(2005)
J Exp Med
, vol.202
, pp. 739-750
-
-
Heissig, B.1
Rafii, S.2
Akiyama, H.3
Ohki, Y.4
Sato, Y.5
Rafael, T.6
Zhu, Z.7
Hicklin, D.J.8
Okumura, K.9
Ogawa, H.10
Werb, Z.11
Hattori, K.12
-
145
-
-
0025147371
-
A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
-
Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A. 1990;87:6624-6628.
-
(1990)
Proc Natl Acad Sci U S A
, vol.87
, pp. 6624-6628
-
-
Good, D.J.1
Polverini, P.J.2
Rastinejad, F.3
Le Beau, M.M.4
Lemons, R.S.5
Frazier, W.A.6
Bouck, N.P.7
-
146
-
-
0025370524
-
Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor
-
Taraboletti G, Roberts D, Liotta LA, Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol. 1990;111:765-772.
-
(1990)
J Cell Biol
, vol.111
, pp. 765-772
-
-
Taraboletti, G.1
Roberts, D.2
Liotta, L.A.3
Giavazzi, R.4
-
147
-
-
0027970092
-
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
-
O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315-328.
-
(1994)
Cell
, vol.79
, pp. 315-328
-
-
O'Reilly, M.S.1
Holmgren, L.2
Shing, Y.3
Chen, C.4
Rosenthal, R.A.5
Moses, M.6
Lane, W.S.7
Cao, Y.8
Sage, E.H.9
Folkman, J.10
-
148
-
-
0031454617
-
Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
-
O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277-285.
-
(1997)
Cell
, vol.88
, pp. 277-285
-
-
O'Reilly, M.S.1
Boehm, T.2
Shing, Y.3
Fukai, N.4
Vasios, G.5
Lane, W.S.6
Flynn, E.7
Birkhead, J.R.8
Olsen, B.R.9
Folkman, J.10
-
149
-
-
0029944122
-
Angiostatin induces and sustains dormancy of human primary tumors in mice
-
O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med. 1996;2:689-692.
-
(1996)
Nat Med
, vol.2
, pp. 689-692
-
-
O'Reilly, M.S.1
Holmgren, L.2
Chen, C.3
Folkman, J.4
-
150
-
-
20144379162
-
Endogenous inhibitors of angiogenesis
-
Nyberg P, Xie L, Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Res. 2005;65:3967-3979.
-
(2005)
Cancer Res
, vol.65
, pp. 3967-3979
-
-
Nyberg, P.1
Xie, L.2
Kalluri, R.3
-
151
-
-
0034210660
-
Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis
-
Dixelius J, Larsson H, Sasaki T, Holmqvist K, Lu L, Engstrom A, Timpl R, Welsh M, Claesson-Welsh L. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood. 2000;95:3403-3411.
-
(2000)
Blood
, vol.95
, pp. 3403-3411
-
-
Dixelius, J.1
Larsson, H.2
Sasaki, T.3
Holmqvist, K.4
Lu, L.5
Engstrom, A.6
Timpl, R.7
Welsh, M.8
Claesson-Welsh, L.9
-
152
-
-
0035970051
-
Interaction of endostatin with integrins implicated in angiogenesis
-
Rehn M, Veikkola T, Kukk-Valdre E, Nakamura H, Ilmonen M, Lombardo C, Pihlajaniemi T, Alitalo K, Vuori K. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci U S A. 2001;98:1024-1029.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 1024-1029
-
-
Rehn, M.1
Veikkola, T.2
Kukk-Valdre, E.3
Nakamura, H.4
Ilmonen, M.5
Lombardo, C.6
Pihlajaniemi, T.7
Alitalo, K.8
Vuori, K.9
-
153
-
-
0141621070
-
Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity
-
Wickstrom SA, Alitalo K, Keski-Oja J. Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity. J Biol Chem. 2003;278:37895-37901.
-
(2003)
J Biol Chem
, vol.278
, pp. 37895-37901
-
-
Wickstrom, S.A.1
Alitalo, K.2
Keski-Oja, J.3
-
154
-
-
0037016498
-
Tumstatin, an endothelial cell-specific inhibitor of protein synthesis
-
Maeshima Y, Sudhakar A, Lively JC, Ueki K, Kharbanda S, Kahn CR, Sonenberg N, Hynes RO, Kalluri R. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science. 2002;295:140-143.
-
(2002)
Science
, vol.295
, pp. 140-143
-
-
Maeshima, Y.1
Sudhakar, A.2
Lively, J.C.3
Ueki, K.4
Kharbanda, S.5
Kahn, C.R.6
Sonenberg, N.7
Hynes, R.O.8
Kalluri, R.9
-
156
-
-
0030930671
-
Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth
-
Cao Y, Chen A, An SS, Ji RW, Davidson D, Llinas M. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem. 1997;272:22924-22928.
-
(1997)
J Biol Chem
, vol.272
, pp. 22924-22928
-
-
Cao, Y.1
Chen, A.2
An, S.S.3
Ji, R.W.4
Davidson, D.5
Llinas, M.6
-
157
-
-
0036544676
-
A peptide derived from human prothrombin fragment 2 inhibits prothrombinase and angiogenesis
-
Kim BJ, Koo SY, Kim SS. A peptide derived from human prothrombin fragment 2 inhibits prothrombinase and angiogenesis. Thromb Res. 2002;106:81-87.
-
(2002)
Thromb Res
, vol.106
, pp. 81-87
-
-
Kim, B.J.1
Koo, S.Y.2
Kim, S.S.3
-
158
-
-
0034651013
-
Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis
-
Colman RW, Jameson BA, Lin Y, Johnson D, Mousa SA. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Blood. 2000;95:543-550.
-
(2000)
Blood
, vol.95
, pp. 543-550
-
-
Colman, R.W.1
Jameson, B.A.2
Lin, Y.3
Johnson, D.4
Mousa, S.A.5
-
159
-
-
17544363650
-
A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo
-
Guo Y, Higazi AA, Arakelian A, Sachais BS, Cines D, Goldfarb RH, Jones TR, Kwaan H, Mazar AP, Rabbani SA. A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo. FASEB J. 2000;14:1400-1410.
-
(2000)
FASEB J
, vol.14
, pp. 1400-1410
-
-
Guo, Y.1
Higazi, A.A.2
Arakelian, A.3
Sachais, B.S.4
Cines, D.5
Goldfarb, R.H.6
Jones, T.R.7
Kwaan, H.8
Mazar, A.P.9
Rabbani, S.A.10
-
160
-
-
26444478703
-
Angiostatin's molecular mechanism: Aspects of specificity and regulation elucidated
-
Wahl ML, Kenan DJ, Gonzalez-Gronow M, Pizzo SV. Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated. J Cell Biochem. 2005;96:242-261.
-
(2005)
J Cell Biochem
, vol.96
, pp. 242-261
-
-
Wahl, M.L.1
Kenan, D.J.2
Gonzalez-Gronow, M.3
Pizzo, S.V.4
-
161
-
-
0942287729
-
Alphastatin, a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo
-
Staton CA, Brown NJ, Rodgers GR, Corke KP, Tazzyman S, Underwood JC, Lewis CE. Alphastatin, a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo. Blood. 2004;103:601-606.
-
(2004)
Blood
, vol.103
, pp. 601-606
-
-
Staton, C.A.1
Brown, N.J.2
Rodgers, G.R.3
Corke, K.P.4
Tazzyman, S.5
Underwood, J.C.6
Lewis, C.E.7
-
162
-
-
0038476608
-
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
-
Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest. 2003;111:1287-1295.
-
(2003)
J Clin Invest
, vol.111
, pp. 1287-1295
-
-
Bergers, G.1
Song, S.2
Meyer-Morse, N.3
Bergsland, E.4
Hanahan, D.5
-
163
-
-
0030661882
-
Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer
-
Nielsen BS, Sehested M, Kjeldsen L, Borregaard N, Rygaard J, Dano K. Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer. Lab Invest. 1997;77:345-355.
-
(1997)
Lab Invest
, vol.77
, pp. 345-355
-
-
Nielsen, B.S.1
Sehested, M.2
Kjeldsen, L.3
Borregaard, N.4
Rygaard, J.5
Dano, K.6
-
164
-
-
1642300508
-
Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment
-
Chantrain CF, Shimada H, Jodele S, Groshen S, Ye W, Shalinsky DR, Werb Z, Coussens LM, DeClerck YA. Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Res. 2004;64:1675-1686.
-
(2004)
Cancer Res
, vol.64
, pp. 1675-1686
-
-
Chantrain, C.F.1
Shimada, H.2
Jodele, S.3
Groshen, S.4
Ye, W.5
Shalinsky, D.R.6
Werb, Z.7
Coussens, L.M.8
DeClerck, Y.A.9
-
165
-
-
0029793759
-
Aminopeptidase a is a constituent of activated pericytes in angiogenesis
-
Schlingemann RO, Oosterwijk E, Wesseling P, Rietveld FJ, Ruiter DJ. Aminopeptidase a is a constituent of activated pericytes in angiogenesis. J Pathol. 1996;179:436-442.
-
(1996)
J Pathol
, vol.179
, pp. 436-442
-
-
Schlingemann, R.O.1
Oosterwijk, E.2
Wesseling, P.3
Rietveld, F.J.4
Ruiter, D.J.5
-
166
-
-
0030901104
-
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3
-
Anand-Apte B, Pepper MS, Voest E, Montesano R, Olsen B, Murphy G, Apte SS, Zetter B. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci. 1997;38:817-823.
-
(1997)
Invest Ophthalmol Vis Sci
, vol.38
, pp. 817-823
-
-
Anand-Apte, B.1
Pepper, M.S.2
Voest, E.3
Montesano, R.4
Olsen, B.5
Murphy, G.6
Apte, S.S.7
Zetter, B.8
-
167
-
-
0034805778
-
Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity
-
Lafleur MA, Forsyth PA, Atkinson SJ, Murphy G, Edwards DR. Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity. Biochem Biophys Res Commun. 2001;282:463-473.
-
(2001)
Biochem Biophys Res Commun
, vol.282
, pp. 463-473
-
-
Lafleur, M.A.1
Forsyth, P.A.2
Atkinson, S.J.3
Murphy, G.4
Edwards, D.R.5
-
168
-
-
0031834239
-
A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
-
Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development. 1998;125:1591-1598.
-
(1998)
Development
, vol.125
, pp. 1591-1598
-
-
Benjamin, L.E.1
Hemo, I.2
Keshet, E.3
-
169
-
-
0032952010
-
Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
-
Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest. 1999;103:159-165.
-
(1999)
J Clin Invest
, vol.103
, pp. 159-165
-
-
Benjamin, L.E.1
Golijanin, D.2
Itin, A.3
Pode, D.4
Keshet, E.5
-
171
-
-
27144528567
-
Arteriogenic growth factors, chemokines and proteases as a prerequisite for arteriogenesis
-
Heil M, Schaper W. Arteriogenic growth factors, chemokines and proteases as a prerequisite for arteriogenesis. Drug News Perspect. 2005;18:317-322.
-
(2005)
Drug News Perspect
, vol.18
, pp. 317-322
-
-
Heil, M.1
Schaper, W.2
-
172
-
-
0037192458
-
Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
-
Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002;295:2387-2392.
-
(2002)
Science
, vol.295
, pp. 2387-2392
-
-
Coussens, L.M.1
Fingleton, B.2
Matrisian, L.M.3
-
173
-
-
0035970094
-
Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels
-
Quax PH, Lamfers ML, Lardenoye JH, Grimbergen JM, de Vries MR, Slomp J, de Ruiter MC, Kockx MM, Verheijen JH, van Hinsbergh VWM. Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels. Circulation. 2001;103:562-569.
-
(2001)
Circulation
, vol.103
, pp. 562-569
-
-
Quax, P.H.1
Lamfers, M.L.2
Lardenoye, J.H.3
Grimbergen, J.M.4
De Vries, M.R.5
Slomp, J.6
De Ruiter, M.C.7
Kockx, M.M.8
Verheijen, J.H.9
Van Hinsbergh, V.W.M.10
-
174
-
-
0038030860
-
De novo vasculogenesis in the heart
-
Luttun A, Carmeliet P. De novo vasculogenesis in the heart. Cardiovasc Res. 2003;58:378-389.
-
(2003)
Cardiovasc Res
, vol.58
, pp. 378-389
-
-
Luttun, A.1
Carmeliet, P.2
-
175
-
-
0036780251
-
Clinical translation of angiogenesis inhibitors
-
Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer. 2002;2:727-739.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 727-739
-
-
Kerbel, R.1
Folkman, J.2
|